Does antihypertensive therapy improve echocardiographic and electrocardiographic parameters of left ventricular hypertrophy in patients with hypertension?
Adequate blood pressure control with antihypertensive therapy for 1 to 2 years can reverse echocardiographic signs of left ventricular hypertrophy and improve ejection fraction.
The changes of left ventricular anatomy and function following treatment with antihypertensive agents for 1 to 2 years were studied by echo-cardiography in 34 patients with hypertension whose blood pressures and electrocardiographic voltages (SV1+RV5) were significantly decreased (p less than 0.001 and 0.01, respectively). The drugs administered or used were trichlormethiazide, beta-blockers, alpha-methyldopa, clonidine hydrochloride, and guanethidine. Most patients received 2 or more of the above drugs. The interventricular septal thickness, the left ventricular posterior wall thickness, the calculated left ventricular mass, the atrial dimensions, all decreased following treatment of hypertension for 1 to 2 years (p less than 0.001-0.05), and the ejection fraction improved (p less than 0.001). It is concluded that cardiac hypertrophy is not irreversible in patients with hypertension if their blood pressure is adequately controlled.
Sonotani et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: